2018 - ECTD Submissions 2018 - Common Technical Document Guidelines

Overview:
The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD - Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies. Reformatting for multiple submissions is substantially limited. The CTD has improved the regulatory review processes and enabled implementation of good review practices. The eCTD has increased efficiency for reviewers and improved submission times. Beginning in May 2017, the eCTD will be required in the US for all marketing applications.
Why should you attend:
This webinar will provide you with information to ensure that you are ready for implementing the mandated requirements of the CTD/eCTD.
Areas Covered in the Session:
• Overview of the drug development program and source of relevant submission documents
• Discussion of the roles and responsibilities for CTD preparation
• Review of the CTD format requirements
• Discussion on the successful transition from other formats to the CTD
• Implementing tools for the project management of CTD preparation and publishing
• Technical requirements for an eCTD submission
• Document naming requirements
• Building the folder structure
• Performing "pre-publishing" work for each document
• Tools for tracking and managing eCTD content
• Performing quality checks on the eCTD
• Updating content in the CTD and eCTD (amendments, supplements, variations, etc.)
Who will benefit:
• Regulatory Affairs
• Quality Assurance
• Pharmacovigilance
• Project Management
• Regulatory Operations
• Anyone responsible for providing content for the CTD
Agenda:
Day 1 Schedule
Lecture 1:
Overview of the drug development program and source of relevant submission documents
Lecture 2:
Discussion of the roles and responsibilities for CTD preparation
Lecture 3:
Review of the CTD format requirements
Lecture 4:
Discussion on the successful transition from other formats to the CTD
Lecture 5:
Implementing tools for the project management of CTD preparation and publishing
Lecture 6:
Technical requirements for an eCTD submission
Day 2 Schedule
Lecture 1:
Document naming requirements
Lecture 2:
Building the folder structure
Lecture 3:
Performing "pre-publishing" work for each document
Lecture 4:
Tools for tracking and managing eCTD content
Lecture 5:
Performing quality checks on the eCTD
Lecture 6:
Updating content in the CTD and eCTD (amendments, supplements, variations, etc.)
Speaker
Peggy Berry
President/CEO, Cooke Consulting Inc.
Peggy J. Berry, MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. Prior to founding Synergy Consulting in 2015, she was Vice President of Regulatory Affairs at Insmed (2/2015-5/2015) where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department. Prior to Insmed, she was Vice President of Regulatory Affairs and Quality at Amarin (3/2009-2/2014). She has also held a variety of senior level positions at Dyax (5/2006-3/2009), MGI Pharma (now Eisai; 7/2005-5/2006), AstraZeneca (10/2001-7/2005), and Dey Pharma (now Mylan; 12/1997-10/2001). She has also held Regulatory Affairs roles within two clinical contract research organizations (ILEX Oncology and Cato Research Ltd; 1992-1997) and has worked in review divisions at the FDA (1985-1992). In addition, Ms. Berry consults for a number of companies in the regulatory and quality area, conducts a number of training courses, and is active in the Regulatory Affairs Professionals Society. She is the editor of the 2010 book "Choosing the Right Regulatory Career" (RAPS, MD) and author of the 2011 book "Communication & Negotiation" (RAPS, MD).
Location: Baltimore, MD Date: April 5th & 6th, 2018 and Time: 9:00 AM to 6:00 PM
Venue: The DoubleTree Baltimore-BWI Airport 890 Elkridge Landing Road - Linthicum, MD 21090
Price:
Register now and save $200. (Early Bird)
Price: $1,295.00 (Seminar Fee for One Delegate)
Until February 28, Early Bird Price: $1,295.00 From March 01 to April 02, Regular Price: $1,495.00
Register for 5 attendees Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*
Register for 10 attendees Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*
Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar
At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.
As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.
For More Information- https://www.globalcompliancepanel.com/control/spon...
Contact us today!
NetZealous LLC DBA GlobalCompliancePanel
john.robinson-AT-globalcompliancepanel.com
support-AT-globalcompliancepanel.com
Toll free: +1-800-447-9407
Phone: +1-510-584-9661
Website: http://www.globalcompliancepanel.com
Registration Link - https://www.globalcompliancepanel.com/control/glob...
Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancep...
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalComplian...
Follow us on Twitter: https://twitter.com/GCPanel